期刊文献+

硫普罗宁治疗青少年非酒精性脂肪肝疗效评价 被引量:2

Evaluation the curative effect of tiopronin on youngsters" non-alcoholic fatty liver.
下载PDF
导出
摘要 目的:评价硫普罗宁治疗青少年非酒精性脂肪肝的疗效。方法:将符合诊断标准的60例患者随机分为治疗组和对照组,治疗组应用硫普罗宁片2片/次,tid,4周为一个疗程;对照组口服护肝片4片/次,tid,4周为1个疗程;两组基础治疗相同。治疗结束后复查生化指标、肝脏CT或B超。结果:治疗组在生化指标及有效率上均优于对照组,结果有统计学意义(P<0.05)。结论:应用硫普罗宁片治疗青少年NAFLD,不但能降低ALT、AST,而且能降低TC和TG,效果优于护肝片。 Objectives:Evaluation the curative effect of fiopronin on youngsters' non-alcoholic fatty liver. Method:Divide 60 satisfactory patients into treatment group and control groups. The treatment group receives Tiopronin orally, two pills/time, three times a day four weeks a course ; Control group receives liver protection pills orally, 4plUs/time, three times a day and four weeks a course .they are of the same base treatment. After the treatment, examine the biochemical index, liver CT or B-ultrasotmd. Results:the treatment group is more efficiency than the control group on Biochemical indicators. The result has an statistical significance (P〈0.05).Conciusion:use Tiopronin Tablets to treat nalld can not only reduce ALT,AST, but also reduce TC and TG, the effect is better than liver protection pills.
作者 肖华勇
机构地区 江油市人民医院
出处 《内蒙古中医药》 2011年第4期95-96,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 青少年 非酒精性脂肪肝 硫普罗宁 youngster non-alcoholic fatty liver Tlopromn
  • 相关文献

参考文献5

二级参考文献18

  • 1范建高 曾民德.脂肪肝的一般药物治疗[A].范建高曾民德主编.脂肪肝[C].上海:上海医科大学出版社,2000.230.
  • 2Marceau P, Biron S, Hould F S, et al. Liver pathology andthe metabolic syndrome X in severe obesity[J].J Clin Endocrinol Metab,1999,84:1513-1517.
  • 3Kawasaki T, Hashimoto N. The relationship between fattyliver and hyperinsulinemia in obese Japanese children[J].J PediatrGastroenterol Nutr,1997,24:317-321.
  • 4Knobler H, Schattner A, Zhornicki T, et al. Fatty liver-an additional and treatable feature of the insulin resistance syndrome[J].Q J Med,1999,92:73-79.
  • 5Lee J H, Rhee P L, Lee J K, et al. Role ofhyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholicfatty liver in patients with normal body weight[J].Korean J Intern Med,1998,13:12-14.
  • 6Sanyal A J,Campbell Sarget C,Mirshahi F,et al.Nonalcoholicsteatohepatitis: association of insulin resistance and mitochondrial abnormalities[J].Gastroenterology,2001,120:1183-1192.
  • 7Scheen A J, Lefebvre P J. Insulin action in man[J].Diabetes Metab,1996,22:105-110.
  • 8Day C P, James O F W. Steatohepatitis: A tale of two ‘hit'?[J].Gastroenterology,1998,114:842-845.
  • 9Valenti L, Fracanzani A L, Dongiovanni P, et al.Tumornecrosis factor alpha promoter polymorphisms and insulin resistance innonalcoholic fatty liver disease[J].Gasteroenterology,2002,122:274-280.
  • 10McClain C J, Barve S, Deaciue I, et al. Cytokines inalcoholic liver disease[J].Semin Liver Dis,1999,19:205-219.

共引文献1479

同被引文献15

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部